Company / Interest Expense
NewAmsterdam Pharma Co N.V. Interest Expense History
FY2021-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$287.0K
FY2022
5-year range
$287.0K / $411.0K
FY2021-FY2022
Trend
-30.2%
vs FY2021
Sector context
#41 of 47
Health Care
What the data says
NewAmsterdam Pharma Co N.V.'s interest expense of $287,000 is lower than 87% of companies in the Health Care sector (FY2022).
Based on SEC 10-K filings.
$287,000 in FY2022.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 47This company $287.0K Sector average $275.6M
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2022, interest expense decreased 30.2% year-over-year.
- Ranks #41 out of 47 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $287.0K | -30.2% |
| FY2021 | $411.0K | - |
As of FY2022 · SEC 10-K · Updated Feb 28, 2026